41 – 50 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Insulin resistance is inversely related to prostate cancer : A prospective study in Northern Sweden
(
- Contribution to journal › Article
- 2006
-
Mark
CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden
(
- Contribution to journal › Article
- 2005
-
Mark
Testosterone as a predictor of pathological stage in clinically localized prostate cancer
(
- Contribution to journal › Article
-
Mark
Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade
(
- Contribution to journal › Article
-
Mark
Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project
(
- Contribution to journal › Article
- 2004
-
Mark
The risk of finding focal cancer (less than 3 mm) remains high on re-biopsy of patients with persistently increased prostate specific antigen but the clinical significance is questionable
(
- Contribution to journal › Article
-
Mark
Evaluation of microwave thermotherapy with histopathology, magnetic resonance imaging and temperature mapping
(
- Contribution to journal › Article
- 2003
-
Mark
Inhibition of dendropoiesis by tumor derived and purified prostate specific antigen
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
(
- Contribution to journal › Article